Vixtimotamab

Product Graph
416€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Vixtimotamab
category
Biosimilars
provider
Abbexa
reference
abx831710
tested applications
ELISA, WB

Description

Vixtimotamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3E/CD33, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody), Kappa, Lambda.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Biosimilars
Immunogen Target
CD3E/CD33
Host
Human, Mouse
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Expression
Recombinant
Purity
> 95%
Purification
Purified from cell culture supernatants by Protein A/G chromatography.
Size 1
100 µg
Size 2
1 mg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
0.01 M PBS. pH 7.4.
Availability
Shipped within 7-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
Biosimilars
Status
RUO
Note
Concentration: Batch-dependent, typically between 0.5-2.0 mg/ml.

CAS Number: 2243775-32-6

This product is for research use only.  Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products
AA E-1000
Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
AA E-1000R
Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
AA E-1100
DHEA-S ELISA
Enzyme immunoassay for the direct quantitative determination of DHEA-S in human serum.
Ver Producto